Medicare to cover COVID-19 tests for nursing home patients
Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and patients through the remainder of the public health emergency, the Centers for Medicare & Medicaid Services announced Friday.
The Centers for Disease Control and Prevention recently recommended testing all nursing home residents and patients with COVID-19 symptoms or potential exposure. MA plans must continue not to charge cost sharing (including deductibles, copayments and coinsurance) or apply prior authorization or other utilization management requirements for COVID-19 tests and testing-related services, CMS notes.
Related News Articles
Perspective
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…
Headline
The Centers for Medicare & Medicaid Services has released details on downloading its upcoming fiscal year 2025 Program for Evaluating Payment Patterns…
Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA. “This report is long on rhetoric and…
Headline
The AHA May 7 wrote to House and Senate lawmakers in support of the Medicare Advantage Improvement Act (H.R. 8375/S. 4384), bipartisan and bicameral…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…